These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26332574)

  • 21. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
    Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
    Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
    Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
    J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesis.
    Burcham GN; Cresswell GM; Snyder PW; Chen L; Liu X; Crist SA; Henry MD; Ratliff TL
    Am J Pathol; 2014 Dec; 184(12):3176-91. PubMed ID: 25455686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-β-dependent activation of matrix metalloproteases.
    Romero D; Al-Shareef Z; Gorroño-Etxebarria I; Atkins S; Turrell F; Chhetri J; Bengoa-Vergniory N; Zenzmaier C; Berger P; Waxman J; Kypta R
    Carcinogenesis; 2016 Jan; 37(1):18-29. PubMed ID: 26503968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.
    Liu KC; Huang AC; Wu PP; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG
    Oncol Rep; 2011 Jul; 26(1):177-84. PubMed ID: 21503582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
    Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
    PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.
    Svensson RU; Haverkamp JM; Thedens DR; Cohen MB; Ratliff TL; Henry MD
    Am J Pathol; 2011 Jul; 179(1):502-12. PubMed ID: 21703427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells.
    Price RS; Cavazos DA; De Angel RE; Hursting SD; deGraffenried LA
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):135-43. PubMed ID: 22333686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
    Castellano G; Malaponte G; Mazzarino MC; Figini M; Marchese F; Gangemi P; Travali S; Stivala F; Canevari S; Libra M
    Clin Cancer Res; 2008 Nov; 14(22):7470-80. PubMed ID: 19010864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
    Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
    Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
    Martin del Campo SE; Latchana N; Levine KM; Grignol VP; Fairchild ET; Jaime-Ramirez AC; Dao TV; Karpa VI; Carson M; Ganju A; Chan AN; Carson WE
    PLoS One; 2015; 10(1):e0115919. PubMed ID: 25587717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
    Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
    Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
    London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
    Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
    Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
    Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN.
    Li Y; Zhang DW; Lin DQ; Cao LQ
    Mol Med Rep; 2015 Oct; 12(4):6255-60. PubMed ID: 26299428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
    Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.
    Salah M; Nishimoto Y; Kohno S; Kondoh A; Kitajima S; Muranaka H; Nishiuchi T; Ibrahim A; Yoshida A; Takahashi C
    Mol Carcinog; 2016 Dec; 55(12):1974-1989. PubMed ID: 26621780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy.
    Fogarasi M; Janssen A; Weber BH; Stöhr H
    Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
    Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
    Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma.
    Adisetiyo H; Liang M; Liao CP; Aycock-Williams A; Cohen MB; Xu S; Neamati N; Conway EM; Cheng CY; Nikitin AY; Roy-Burman P
    PLoS One; 2013; 8(7):e69484. PubMed ID: 23936028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.